
Rethinking Alzheimer’s Drug Approaches
A thorough review raises questions about the effectiveness and safety of drugs targeting amyloid proteins in Alzheimer’s treatment.
Tarlatamab Brings New Possibilities for Relapsed Small-Cell Lung Cancer
Tarlatamab is emerging as a promising option for improving survival rates in patients with difficult-to-treat small-cell lung cancer.
Navigating Care Challenges in Frontotemporal Dementia
A recent study explores the obstacles faced by patients and caregivers in the Canadian healthcare system.
Our Key Targets To Solve Neurodegeneration

Join The Neurospan Community
Three ways Neurospan creates value
01
Research interpretation
Track meaningful developments, highlight the mechanisms that matter, and make important research easier to follow.
02
Educational media
Turn difficult ideas into articles, explainers, and eventually stronger visual storytelling that helps more people understand the problem.
03
Community building
Bring researchers, contributors, and serious outsiders into a stronger shared mission around preserving long-term cognition.
Discover, track, research, and contribute.
Explainers, clinical tracking, key ideas, and ways to help.
Short visual explainers on the ideas behind neurodegeneration.
